Jamie Heywood is one of the foremost practitioners of personalized technology to transform the future of healthcare. He is a pioneer in engaging patients, understanding their needs and applying entrepreneurial knowledge to develop and improve treatment. He has founded 5 companies: ALS-TDI, PatientsLikeMe (just bought by UnitedHealth), AOBiome, Genetic Networks and the SocialMedwork. Respectively, these companies find treatments for disease, network patients, develop novel therapeutics, advance bioinformatics, and access to novel treatments.
Putting Artificial Intelligence to Work
Jamie provides unique insights into the challenges and benefits of putting artificial intelligence to work to transform healthcare. He explores the big picture of when and where AI will impact our lives, who will be disrupted, and the consequences for the brands and economics of healthcare. Jamie offers a unique voice to the nuanced questions behind the rise of artificial intelligence: tools for understanding biology, health and disease are accelerating faster than Moore's Law, where will it have impact, how do we align incentives, what needs to change to make it happen, and the evolving roles of medical providers in a world with artificial intelligence?
A MIT educated mechanical engineer, Jamie entered the field of translational medicine in 1998 when his brother, Stephen, was diagnosed with ALS (Lou Gehrig’s disease) at the age of 29. He founded ALS Therapy Development Institute (ALS TDI), the world’s first non-profit biotechnology company.
ALS TDI has been one of the most promising and innovative research organizations involved in the study and treatment of ALS. The Institute was a pioneer in modern disease research as the first organization to run an open research program, posting the results of its studies in real time.
Jamie's work has been the subject of His Brother's Keeper, a book by Pulitzer Prize-winning author Jonathan Weiner, and So Much So Fast, a Sundance award-winning documentary. He has also been profiled in The New Yorker and on 60 Minutes.
Jamie is an authentic, provocative, and inspiring speaker.
• “Would love to spend a week learning from him” • “Jamie was excellent. We’re lucky to have thought-leaders like this in our industry…pushing the envelope” • “Excellent, excellent, excellent!” Perhaps more importantly, they were just wonderful people to work with. They were always humble and gracious, and our Board and VIPs thoroughly enjoyed spending a little time with them both.
Jamie’s presentation was very well received by everyone. They particularly appreciated his patient-focused perspective and the creativity and innovation represented by the Patients-Like-Me website. And obviously the story of his brother’s struggles with ALS is quite compelling. And, as we had hoped, Jamie provided a unique perspective on the future of pharmaceutical R&D, one quite different from more traditional approaches. He’s a very accomplished speaker and very engaging. Clearly, Jamie was a very good choice for this meeting.